NCT03120871View on ClinicalTrials.gov

Microbiome Insulin Sensitivity Study

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

August 19, 2018

Study Completion Date

August 19, 2018

Conditions
ObesityInsulin ResistanceType2 Diabetes
Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Children's Hospital Colorado

OTHER

lead

University of Colorado, Denver

OTHER

NCT03120871 - Microbiome Insulin Sensitivity Study | Biotech Hunter | Biotech Hunter